Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02900352 · ClinicalTrials.gov registry record · Phase 3

Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action

A Phase 3 study of Alcohol Use Disorder, sponsored by Virginia Commonwealth University.

Completed
Registry status
Phase 3
Development phase
156
Enrollment target
4
Study locations

NCT02900352 is a Phase 3 study of Alcohol Use Disorder that has completed, run by Virginia Commonwealth University. The registered enrollment target is 156 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (52% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02900352, a Phase 3 study of Alcohol Use Disorder, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
Phase 3
Development phase
156 participants
Enrollment target
4
Study locations

Study Summary

This is a randomized, placebo-controlled, double-blind, 16 week trial of the medication zonisamide for the treatment of heavy drinking alcoholic civilians.

Conditions Studied

Alcohol Use Disorder

Interventions

  • DRUG Placebo
  • DRUG Zonisamide

Study Locations (4)

Connecticut

  • UCONN Health - Farmington
  • Yale University - New Haven
  • West Haven Veterans Affairs - West Haven

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2016-10
Est. Completion 2021-04-22
Phase Phase 3

Sponsor

Virginia Commonwealth University

558 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02900352

The ClinicalTrials.gov registry entry for NCT02900352 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (52% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02900352 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Virginia.

Frequently Asked Questions

What is clinical trial NCT02900352 about?

NCT02900352 is a clinical study titled "Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action". This is a randomized, placebo-controlled, double-blind, 16 week trial of the medication zonisamide for the treatment of heavy drinking alcoholic civilians.

What is the current status of trial NCT02900352?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 156 participants. The study started on 2016-10. Estimated completion is 2021-04-22.

What conditions does trial NCT02900352 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT02900352?

The interventions under investigation include: Placebo (DRUG), Zonisamide (DRUG).

Who is sponsoring clinical trial NCT02900352?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02900352 being conducted?

This trial has 4 study locations across Connecticut, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.